Screener
HealthEquity HQY G&A
G&A at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: HealthEquity’s 10-Q, filed May 28, 2026.
- Filed
- May 28, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001428336-26-000028
| (in thousands, except per share data) | Three months ended April 30, 2026 | Three months ended April 30, 2025 |
|---|---|---|
| Operating expenses | ||
| Sales and marketing | 26,833 | 25,984 |
| Technology and development | 67,767 | 61,436 |
| General and administrative | 31,131 | 25,536 |
| Amortization of acquired intangible assets | 26,515 | 27,002 |
| Merger integration | 1,113 | 1,275 |
| Total operating expenses | 153,359 | 141,233 |
| Income from operations | 102,953 | 83,078 |
Item 1. Financial statements
FAQ
- What is HealthEquity's G&A?
- HealthEquity (HQY) reported G&A of $31.13M in Q1 2026.
- How has HealthEquity's G&A changed year-over-year?
- HealthEquity's G&A increased by 21.9% year-over-year, from $25.54M to $31.13M.
- What is the long-term trend for HealthEquity's G&A?
- Over 4 years (2022 to 2026), HealthEquity's G&A has grown at a 8.8% compound annual growth rate (CAGR), from $85.44M to $119.93M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about HealthEquity's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude